HOME >> BIOLOGY >> NEWS
Don't always believe what you see, suggests study on false memories

f neurology.

The study included 23 young adults with no history of mental impairment. Participants were shown 24 sets of 12 slides. Each set of slides portrayed different geometric shapes, which varied in number, size, position, shape and color.

After studying each group of slides, the participants were shown an additional five slides and asked if they had seen any of the shapes on these additional slides in the original set.

For example, participants were shown a set of 12 slides each showing yellow triangles. Each slide showed one, two or three large or small triangles; multiple triangles were arranged either vertically or horizontally. In this case, the lure slide part of the five additional test slides showed two small yellow triangles lined up horizontally below a large yellow triangle. But while it looked similar to slides in the original group, it wasn't part of the initial set.

Participants accurately identified the images they had seen in the original set 80 percent of the time. They also correctly identified the images that obviously weren't part of the original set of shapes more than 98 percent of the time. But they incorrectly said they had seen the lure images 60 percent of the time.

"False memories can be created using visual stimuli with minimal language input," Beversdorf said. "The question now is whether this can be done entirely without the use of semantics."

Beversdorf plans to apply these findings and this research model to future studies on autistic people.

In previous work, Beversdorf found that some people with autism spectrum disorder (ASD) performed better on a "false-memory" test than did normal control subjects. People with ASD have an impaired ability to use context, and, in a prior study, that inability improved the ASD subjects' ability to discriminate between words that had and had not been on a word list.

"Language impairment is part of the syndrome of autism," Beve
'"/>

Contact: David Beversdorf
Beversdorf-1@medctr.osu.edu
614-293-8531
Ohio State University
8-Nov-2003


Page: 1 2 3

Related biology news :

1. Dont drink the water: Texas A&M researcher conducting study of polluted Mexican lake
2. Dont ban embryo-based research says new chairman of European fertility organisation
3. Dont be fooled about your oral health: AAP uncovers common misconceptions
4. Pain in the gut? Dont blame stomach acid
5. Dont slight the birdbrain
6. HIV-Positive Injection Drug Users Often Dont Receive Protease Inhibitors And May Not Be Aware Of The Drug
7. HIV-1 Levels In Semen Dont Correspond To Viral Levels In Blood, Say Pitt Researchers In A Report At 12th World AIDS Conference
8. Genetic Makeup May Explain Why Some Women Smokers Develop Breast Cancer While Others Dont, UB Study in JAMA Reports
9. Once a renin cell, always a renin cell
10. Bigger isnt always better--especially if youre a rodent
11. Born shy, always shy? Temperamental differences may last throughout life, brain study suggests

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Don always believe what you see suggests study false memories

(Date:10/18/2014)... suspected genetic conditions, a certain type of exome sequencing ... than traditional molecular diagnostic methods, according to a study ... released to coincide with the American Society of Human ... protein­coding region of the genome (the complete set of ... organism), has been rapidly applied in research settings and ...
(Date:10/17/2014)... release is available in German . ... of sperms every day in order to reproduce? And why ... the topic of the latest issue of the research journal ... The evolutionary biologist Steven Ramm from Bielefeld University Bielefeld has ... is not unusual for a female to copulate with several ...
(Date:10/17/2014)... To date, antidotes ... doctors are often limited to supportive therapy such as induced ... of drugs involved. So what can be done if a ... professor Jean-Christophe Leroux from the Institute of Pharmaceutical Sciences at ... "The task was to develop an agent that could eliminate ...
Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Sperm wars 2Emergency aid for overdoses 2Emergency aid for overdoses 3
(Date:10/22/2014)... Oct. 22, 2014   Synthetic Biologics, Inc. ... therapies for serious infections and diseases, announced today that ... Notice of Allowance for a composition of matter patent ... difficile program, SYN-004. This is Synthetic Biologics, first ... U.S. and adds to the Company,s extensive C. ...
(Date:10/22/2014)... and HONG KONG , Oct. ... disease therapeutics enterprise, announced today that rare disease expert ... as vice president, research. Dr. McKew brings more than ... leadership positions at the National Institutes of Health, Wyeth ... by Wyeth). Dr. McKew will lead aTyr,s efforts to expand ...
(Date:10/20/2014)... 20, 2014 Asterias Biotherapeutics, Inc. (NYSE ... signed a Notice of Grant Award (NGA) with ... October 1, 2014.  The NGA provides for the ... release of additional grant funds pursuant to the ... clinical development of Asterias, product, AST-OPC1. The grant ...
(Date:10/20/2014)... BOSTON , Oct. 20, 2014 ... commercialization company tackling big healthcare problems, announced today ... investment round, with participation from Invesco Perpetual, a ... be used to drive PureTech,s existing pipeline forward ... technologies. "PureTech has the scientific creativity to really ...
Breaking Biology Technology:Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6
Cached News: